IBM is lobbying against a bill even though it would extend a favorite bipartisan policy, the federal tax credit for R&D.
IBM and other business lobbies oppose the bill because of provisions that would increase taxes on money earned overseas by U.S. companies, but the Wall Street Journal’s editorial on it the debate is worth reading for some interesting undercurrents.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.